Clene announces registered direct offering of over $28M [Seeking Alpha]
Clene Inc. (CLNN)
Company Research
Source: Seeking Alpha
On January 9, 2026, Clene entered into securities purchase agreements for the issuance and sale of: 928,333 shares of Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities. Subscribe to Newsletters Sign Up Quick Insights The offering is expected to fund Clene into the third quarter of 2026 and, with additional warrant exercises, potentially through the end of 2026 and commercialization efforts. Series A Warrants have a $6.00 exercise price, rising based on milestones, with up to $6.7M in proceeds; Series B Warrants start at $6.00 and may increase to $12.50 based on FDA approval and stock price, with potential proceeds of about $15.6M. Exercise prices of Warrants increase based on timing relative to FDA announcements and if the stock reaches certain price thresholds at those milestones. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
CLNN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLNN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLNN alerts
High impacting Clene Inc. news events
Weekly update
A roundup of the hottest topics
CLNN
News
- Clene to Present at the Emerging Growth ConferenceGlobeNewswire
- Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA MeetingGlobeNewswire
- Clene (NASDAQ:CLNN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.MarketBeat
- Clene Announces Registered Direct Offering of Over $28 MillionGlobeNewswire
- Clene (NASDAQ:CLNN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $23.00 price target on the stock.MarketBeat
CLNN
Sec Filings
- 1/16/26 - Form 4
- 1/13/26 - Form 4
- 1/13/26 - Form 8-K
- CLNN's page on the SEC website